We are live on ! Find out more
RJT

Raymond James Trust Portfolio holdings

AUM $4.6B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+11.09%
1 Year Est. Return
+33.54%
3 Year Est. Return
+41.33%
5 Year Est. Return
+111.23%
10 Year Est. Return
+235.1%
AUM
$2.32B
AUM Growth
+$254M
Cap. Flow
+$91.3M
Cap. Flow %
3.93%
Top 10 Hldgs %
20.67%
Holding
1,016
New
86
Increased
453
Reduced
321
Closed
38

Top Buys

Rank Stock Value
1
RJF icon
Raymond James Financial
RJF
+$14.2M
2
FLGT icon
Fulgent Genetics
FLGT
+$14.1M
3
KO icon
Coca-Cola
KO
+$10.6M
4
HSY icon
Hershey
HSY
+$4.35M
5
AFL icon
Aflac
AFL
+$3.51M

Sector Composition

Rank Sector Weight
1 Technology 16.25%
2 Healthcare 12.65%
3 Financials 9.87%
4 Consumer Staples 8.33%
5 Consumer Discretionary 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXTR icon
951
Extreme Networks
EXTR
$4.23B
$86K ﹤0.01%
21,500
CHX
952
DELISTED
ChampionX
CHX
$85K ﹤0.01%
+10,632
New +$102K
VER
953
DELISTED
VEREIT, Inc.
VER
$78K ﹤0.01%
2,403
-234
-9% -$7.71K
KYN icon
954
Kayne Anderson Energy Infrastructure Fund
KYN
$2.42B
$77K ﹤0.01%
19,260
+7,000
+57% +$33.4K
RJET
955
Republic Airways Holdings
RJET
$1.03B
$77K ﹤0.01%
1,733
MRO
956
DELISTED
Marathon Oil Corporation
MRO
$76K ﹤0.01%
18,640
+2,424
+15% +$12.8K
MIN
957
Aberdeen Intermediate Income Fund
MIN
$275M
$70K ﹤0.01%
18,651
IGD
958
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$513M
$67K ﹤0.01%
13,500
BMY.RT
959
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$66K ﹤0.01%
29,302
-78
-0.3% -$223
OCSL icon
960
Oaktree Specialty Lending
OCSL
$1.07B
$65K ﹤0.01%
4,487
-37
-0.8% -$529
FXN icon
961
First Trust Energy AlphaDEX Fund
FXN
$374M
$63K ﹤0.01%
+11,333
New +$73.8K
BGC icon
962
BGC Group
BGC
$5.25B
$61K ﹤0.01%
25,604
-14,534
-36% -$37.9K
GYRE icon
963
Gyre Therapeutics
GYRE
$686M
$60K ﹤0.01%
+1,867
New +$73.1K
GNT
964
GAMCO Natural Resources, Gold & Income Trust
GNT
$137M
$58K ﹤0.01%
11,646
GAB icon
965
Gabelli Equity Trust
GAB
$1.78B
$54K ﹤0.01%
10,901
CXE
966
DELISTED
MFS High Income Municipal Trust
CXE
$52K ﹤0.01%
11,020
CMU
967
DELISTED
MFS High Yield Municipal Trust
CMU
$46K ﹤0.01%
11,013
NMRK icon
968
Newmark Group
NMRK
$2.8B
$45K ﹤0.01%
10,389
-2,474
-19% -$10.7K
ENZ
969
DELISTED
Enzo Biochem, Inc.
ENZ
$36K ﹤0.01%
17,016
OXY.WS icon
970
Occidental Petroleum Corp Warrants
OXY.WS
$31B
$33K ﹤0.01%
+11,187
New +$35.8K
AEG icon
971
Aegon
AEG
$13.9B
$28K ﹤0.01%
11,872
LYG icon
972
Lloyds Banking Group
LYG
$90.3B
$27K ﹤0.01%
+20,997
New +$29.4K
SENS icon
973
Senseonics Holdings Inc
SENS
$282M
$27K ﹤0.01%
3,550
SAN icon
974
Banco Santander
SAN
$207B
$23K ﹤0.01%
+13,070
New +$28.1K
TXMD icon
975
TherapeuticsMD
TXMD
$23.6M
$19K ﹤0.01%
240

Similar funds

Raymond James Trust's Q3 2020 Portfolio in Review

As of Q3 2020, Raymond James Trust held 1,016 positions worth $2.32B, up 12% from $2.07B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James Trust deployed $91.3M of net new capital in Q3 2020, opening 86 new positions and adding to 453 existing holdings. Its largest new stake was Invesco S&P SmallCap Low Volatility ETF: 28,363 shares worth $942K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Microsoft, an estimated $2.94M trimmed.

  • Raymond James Trust's largest Q3 2020 buy was Invesco S&P SmallCap Low Volatility ETF: 28,363 shares worth $942K.
  • Raymond James Trust added most to Raymond James Financial in Q3 2020, an estimated $14.2M increase.
  • Raymond James Trust's biggest Q3 2020 reduction was Microsoft, cutting an estimated $2.94M.
  • Raymond James Trust fully exited Invesco S&P 500 Pure Value ETF in Q3 2020, selling an estimated $1.34M.
  • Raymond James Trust's ten largest holdings make up 21% of its $2.32B portfolio in Q3 2020.
  • Raymond James Trust opened 86 new positions and closed 38 in Q3 2020.
  • Raymond James Trust's portfolio value rose 12% quarter-over-quarter to $2.32B.

Based on Raymond James Trust's 13F filing for Q3 2020, filed 14 Oct 2020.